87 related articles for article (PubMed ID: 15563762)
1. Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.
Hayashi A; Suzuki M; Sasamata M; Miyata K
J Pharm Pharmacol; 2004 Dec; 56(12):1551-6. PubMed ID: 15563762
[TBL] [Abstract][Full Text] [Related]
2. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
3. Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats.
Hayashi A; Sonoda R; Kimura Y; Takasu T; Suzuki M; Sasamata M; Miyata K
Brain Res; 2004 Jun; 1011(2):221-7. PubMed ID: 15157808
[TBL] [Abstract][Full Text] [Related]
4. Characterization of intracavernous pressure increase induced by Ym348, a novel 5-HT2C receptor agonist, in anesthetized rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
J Urol; 2006 May; 175(5):1953-7. PubMed ID: 16600805
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
[TBL] [Abstract][Full Text] [Related]
6. Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.
Hayashi A; Suzuki M; Sasamata M; Miyata K
Psychopharmacology (Berl); 2005 Mar; 178(2-3):241-9. PubMed ID: 15719229
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.
Shimada I; Maeno K; Kazuta K; Kubota H; Kimizuka T; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Feb; 16(4):1966-82. PubMed ID: 18035544
[TBL] [Abstract][Full Text] [Related]
9. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
10. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
12. Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice.
Stiedl O; Misane I; Koch M; Pattij T; Meyer M; Ogren SO
Neuropharmacology; 2007 Mar; 52(3):949-57. PubMed ID: 17141810
[TBL] [Abstract][Full Text] [Related]
13. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of spinal noradrenergic mechanisms in the antiallodynic effect of intrathecally administered 5-HT2C receptor agonists in the rats with peripheral nerve injury.
Obata H; Ito N; Sasaki M; Saito S; Goto F
Eur J Pharmacol; 2007 Jul; 567(1-2):89-94. PubMed ID: 17451674
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT3 and 5-HT2C receptors located within the medial amygdala in the control of salt intake in sodium-depleted rats.
Luz C; Souza A; Reis R; Fregoneze JB; de Castro e Silva E
Brain Res; 2006 Jul; 1099(1):121-32. PubMed ID: 16765332
[TBL] [Abstract][Full Text] [Related]
17. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
18. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
19. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
Antonatos S; Galanopoulou P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
[TBL] [Abstract][Full Text] [Related]
20. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.
Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA
Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
